CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q1 2022 Portfolio Holders as of 3/31/2022

Type / Class
Equity / NAMEN AKT
Number of holders
404
Total Shares
48.6 M
Shares change
+8.35 M
Total reported value, excl. options
$3.05 B
Value change
+$484 M
Put/Call ratio
0.99
Number of buys
222
Number of sells
-149
Price
$62.77
CUSIP
H17182108
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.